Roivant Sciences Company
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Investors
Technology:
Biopharma, Biotechnology, Health Care, Pharmaceutical, Product Research
Industry:
AI, Clinical Development, Preclinical Development
Headquarters:
New York, New York, United States
Founded Date:
2014-05-01
Employees Number:
501-1000
Funding Status:
IPO
Acquisitions Number:
Made Acquisitions
Investors Number:
15
Total Funding:
2293000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2023-02-02
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership